Women may have better survival than men in Merkle cell carcinoma


February 23, 2021

1 min read


Published by:

Disclosures: Tam reports no relevant financial disclosures. Please see the study for all other authors’ relevant financial disclosures.


Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .



We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Mortality associated with Merkle cell carcinoma may be lower among women compared with men, according to a retrospective study.

“Studies have observed that women have better outcomes than men in melanoma, but less is known about the influence of sex differences on outcomes for other aggressive cutaneous malignancies,” Moses Tam, MD, of the department of radiation oncology at New York University Langone Health, and colleagues wrote.

Tam and colleagues culled patients with nonmetastatic Merkle cell carcinoma (MCC) undergoing surgery and lymph node evaluation from the National Cancer Database (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) database to determine whether women and men have different outcomes in MCC…

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.